Icad Z Score
ICAD  Stock  USD 1.67 0.01 0.60% 
Icad  Z Score 
Icad Z Score Analysis
Icad's ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..2019  2020  2021  2022 (projected)  
Interest Expense  784 K  476 K  141 K  144.71 K 
Gross Profit  24.23 M  21.35 M  24.24 M  22.32 M 
Z Score  =  Sum Of   5 Factors 
Current Icad Z Score  2.8 
Most of Icad's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icad Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Icad Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Icad is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Icad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Icad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Icad's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
According to the company's disclosures, Icad Inc has a Z Score of 2.8. This is 58.52% lower than that of the Health Care Technology sector and 35.48% lower than that of the Health Care industry. The z score for all United States stocks is 67.89% higher than that of the company.
Icad Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icad's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics of similar companies.Icad is currently under evaluation in z score category among related companies.
Icad Current Valuation Drivers
We derive many important indicators used in calculating different scores of Icad from analyzing Icad's financial statements. These drivers represent accounts that assess Icad's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Icad's important valuation drivers and their relationship over time.
2017  2018  2019  2020  2021  2022 (projected)  
Net Income Per Employee  (119.8 K)  (92.96 K)  (98.2 K)  (154.05 K)  (82.08 K)  (88.56 K)  
Revenue Per Employee  236.15 K  264.13 K  227.1 K  259.8 K  245.53 K  282.52 K  
Average Assets  35.47 M  29.1 M  39.29 M  47.28 M  67.5 M  58.43 M  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  (13.17 M)  (8.26 M)  (12.9 M)  (16.98 M)  (10.79 M)  (11.64 M)  
Earnings Before Interest Taxes and Depreciation Amortization USD  (12.66 M)  (7.76 M)  (12.05 M)  (16.52 M)  (10.55 M)  (11.38 M)  
Earnings before Tax  (14.27 M)  (8.97 M)  (13.51 M)  (17.57 M)  (11.24 M)  (12.13 M)  
Average Equity  20.56 M  9.72 M  7.18 M  24.36 M  50.18 M  39.66 M  
Enterprise Value  51.51 M  61.34 M  153.32 M  290.71 M  146.27 M  137.29 M  
Free Cash Flow  (7.73 M)  (4.17 M)  (7.4 M)  (7.45 M)  (9.97 M)  (10.23 M)  
Invested Capital  6.36 M  9.5 M  20.54 M  11.15 M  4.79 M  6.34 M  
Invested Capital Average  3.29 M  5.82 M  16.51 M  10.77 M  8.11 M  8.2 M  
Market Capitalization  56.8 M  62.06 M  150.42 M  303.51 M  180.79 M  160.4 M  
Tangible Asset Value  21.84 M  21.82 M  32.2 M  46.33 M  53.15 M  45.72 M  
Working Capital  9.14 M  7.97 M  10.36 M  25.55 M  35.34 M  38.13 M 
Icad Fundamentals
Return On Equity  (0.34) %  
Return On Asset  (0.15) %  
Profit Margin  (0.50) %  
Operating Margin  (0.50) %  
Current Valuation  24.71 M  
Shares Outstanding  25.45 M  
Shares Owned by Insiders  7.31 %  
Shares Owned by Institutions  48.77 %  
Number of Shares Shorted  332.73 K  
Price to Earning  (8.32) X  
Price to Book  1.23 X  
Price to Sales  1.51 X  
Revenue  33.64 M  
Gross Profit  24.56 M  
EBITDA  (11.15 M)  
Net Income  (11.24 M)  
Cash and Equivalents  27.18 M  
Cash per Share  1.07 X  
Total Debt  3.16 M  
Debt to Equity  0.08 %  
Current Ratio  3.19 X  
Book Value Per Share  1.49 X  
Cash Flow from Operations  (9.41 M)  
Short Ratio  3.99 X  
Earnings Per Share  (0.52) X  
Price to Earnings To Growth  (0.56) X  
Target Price  8.17  
Number of Employees  136  
Beta  1.16  
Market Capitalization  44.28 M  
Total Asset  62.19 M  
Retained Earnings  (242.03 M)  
Working Capital  13.49 M  
Current Asset  27.77 M  
Current Liabilities  14.28 M  
Z Score  2.8  
Net Asset  62.19 M 
About Icad Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Icad Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Icad without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate riskadjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance 
All Next  Launch Module 
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Icad Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Please see Icad Piotroski F Score and Icad Valuation analysis. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your thirdparty portfolios from your local drive in csv format.
Complementary Tools for Icad Stock analysis
When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Performance AnalysisCheck effects of meanvariance optimization against your current asset allocation  Go  
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities  Go  
Portfolio RebalancingAnalyze riskadjusted returns against different time horizons to find assetallocation targets  Go  
Volatility AnalysisGet historical volatility and risk analysis based on latest market data  Go  
ETF DirectoryFind actively traded Exchange Traded Funds (ETF) from around the world  Go  
Analyst RecommendationsAnalyst recommendations and target price estimates broken down by several categories  Go  
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and riskadjusted market performance  Go  
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on selflearning algorithm to remember stocks you like  Go  
Portfolio File ImportQuickly import all of your thirdparty portfolios from your local drive in csv format  Go  
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments  Go  
Stock ScreenerFind equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.  Go  
CEO DirectoryScreen CEOs from public companies around the world  Go  
Financial WidgetsEasily integrated Macroaxis content with over 30 different plugandplay financial widgets  Go 
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization 44.3 M  Quarterly Revenue Growth YOY (0.32)  Return On Assets (0.15)  Return On Equity (0.34) 
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.